(Total Views: 514)
Posted On: 03/02/2022 5:31:17 AM
Post# of 145249
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: KenChowder #119366
Quote:
I can't be sure there is a connection, but it would make sense for them to be using data about Leronlimab's ability to ameliorate "severe Covid-19 manifestations" from our Brazilian trial.
Yeah sure. They use data from a randomized, double blinded trial which was by far not completed or ready for interim analysis for a report dated Feb. 10th. (we had roughly 30 patients of the 612 patients enrolled in the beginning of January).
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)